Pharmacovigilance and Spontaneous Reporting Trends of Adverse Drug Reactions in Ghana
The Global Health Network Collections · 13.06.2023
DOI: 10.21428/3d48c34a.69f4bcd7 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Global Health Network Collections, online erschienen am 13.06.2023. Verfasst von Walter-Rodney Nagumo.
Abstract (Originalsprache)
. Several studies have shown the impact of ADRs and associated non-reporting of events on healthcare systems. Pharmacovigilance (PV) and ADR reporting activities are decentralised from the national to the regional level through regional PV officers who are linked to Institutional Contact Persons (ICP) in healthcare facilities locally in Ghana. The Food and Drug Authority (FDA) has consistently been reporting below the WHO recommendation of 200 reports per million population despite increased efforts by the FDA to raise awareness and provide training to stakeholders. A safety monitoring unit within the FDA coordinates safety reporting cooperatively with the National Pharmacovigilance Centre (NPC).
Zitieren
APA
Nagumo, W. (2023). Pharmacovigilance and Spontaneous Reporting Trends of Adverse Drug Reactions in Ghana. The Global Health Network Collections. https://doi.org/10.21428/3d48c34a.69f4bcd7
Vancouver
Nagumo W. Pharmacovigilance and Spontaneous Reporting Trends of Adverse Drug Reactions in Ghana. The Global Health Network Collections. 2023. doi:10.21428/3d48c34a.69f4bcd7
BibTeX
@article{Nagumo2023,
author = {Nagumo, Walter-Rodney},
title = {Pharmacovigilance and Spontaneous Reporting Trends of Adverse Drug Reactions in Ghana},
journal = {The Global Health Network Collections},
year = {2023},
doi = {10.21428/3d48c34a.69f4bcd7}
}
EUVIMED